417 Wakara Way, Suite 3510, Salt Lake City, UT 84108, USA       info@upstartvc.com  |   USA [1] 801-505-0630

© 2018 by UpStart VC

  • Facebook - Black Circle
  • Twitter - Black Circle

OUR NEWS

June 8, 2018

SALT LAKE CITY -- (BUSINESS WIRE) -- XableCath, Inc., innovators of products designed to aid in the treatment of peripheral artery disease (PAD), announced that its second catheter, XableCath™ abrasion tip support catheter, was cleared by the FDA. The XableCath blunt t...

April 23, 2018

Q Therapeutics, Inc., a developer of clinical-stage cell therapies for central nervous system (CNS) diseases, and REPROCELL Inc., Japan’s first induced pluripotent stem cell (iPSC) company, announced the formation of MAGiQ Therapeutics, Inc., a Japanese joint venture c...

December 18, 2017

XableCath, a clinical stage medical device company, announced its XableCath blunt tip support catheter has received clearance from the U.S. Food and Drug Administration. The blunt tip catheter facilitates true lumen passage of lesions, both above and below the knee, in...

December 13, 2017

SALT LAKE CITY and YOKOHAMA, Japan, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Q Therapeutics, Inc., a developer of clinical-stage cell therapies for central nervous system (CNS) disease and injury, announced a collaborative research agreement with REPROCELL Inc. that combines...

LabCorp® (NYSE: LH) today announced the nationwide availability of the PreTRM® test. Developed by Sera Prognostics, Inc., the PreTRM test is the first of its kind validated blood test that provides an early and individualized prediction of preterm birth risk for pregna...

Please reload

IN THE MEDIA

XABLECATH FEATURED IN MEDTECH STRATEGIST AS A STARTUP TO WATCH IN 2018

Salt Lake City, UT – May 11, 2018 – UpStart portfolio company Xablecath offering peripheral vascular interventional tech- nologies appears in the "START-UPS TO WATCH" section of the May edition of MedTech Strategist. 

READ MORE

SERA PROGNOSTICS IS NAMED A 2017 SILVER EDISON AWARD WINNER

New York, NY – April 21, 2017 – The Edison Awards, celebrating 30 years of honoring the best in innovation and excellence in the development of new products and services, announced today that Sera Prognostics’ PreTRM Test was voted a Silver Winner for innovation in the “Health and Wellness” category at the April 20th event at The Capitale in New York City. 

READ MORE